Discontinued — last reported Q4 '23
Cardinal Health Pharmaceutical — Goodwill remained flat by 0.0% to $2.65B in Q4 2023 compared to the prior quarter. Year-over-year, this metric declined by 0.9%, from $2.67B to $2.65B. Over 2 years (FY 2021 to FY 2023), Pharmaceutical — Goodwill shows relatively stable performance with a 0.2% CAGR.
An increase indicates recent M&A activity, while a decrease may suggest impairment charges or divestitures.
This represents the excess of the purchase price over the fair value of identifiable net assets acquired in business com...
Standard across large-cap healthcare distributors that utilize M&A to expand service offerings or geographic reach.
cah_segment_pharmaceutical_goodwill| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.66B | $2.66B | $2.66B | $2.66B | $2.67B | $2.67B | $2.67B | $2.67B | $2.65B | $2.65B | $2.65B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.5% | +0.0% | +0.0% | +0.0% | -0.9% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +0.5% | +0.5% | +0.5% | +0.5% | -0.9% | -0.9% | -0.9% |